Comparison Chart Biogen Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 10:19:05 2024-09-18 am EDT			5-day change	1st Jan Change
198.48 ^USD	+0.14%		-0.44%	-23.40%

Sep. 17	Biogen New Drug Submission for Friedreich's Ataxia Treatment Accepted for Priority Review in Canada	MT
Sep. 17	INmune Bio, Inc. Announces Results of Additional Blinded Interim Analysis of Phase 2 Alzheimer's Disease Trial Demonstrating Correlation between EMACC and CDR-SB Endpoints	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	BIOGEN INC.	Biopharmaceuticals	-0.06%	-0.44%	-23.40%	-21.74%	-15.71%	28.87B